Auspex Pharmaceuticals Strengthens Executive Management Team

Published: Apr 09, 2009

VISTA, Calif.--(BUSINESS WIRE)--Auspex Pharmaceuticals, a developer of next-generation medicines through the targeted deuteration of clinically validated drugs, today announced three key management hires. The company has appointed Ronald C. Newbold, Ph.D., as Chief Business Officer; Andreas Sommer, Ph.D., as Vice President, Operations; and Tadimeti Rao, Ph.D., as Vice President, Preclinical Development.

Back to news